The private equity industry is in the midst of a hiring surge. Not for deal makers or portfolio operators-roles that have been constant for decades. Instead, private equity firms are racing to build C-suite positions around artificial intelligence and data. Coverage from PE Professional details how Reeve Waud is positioning itself as a leader in this transformation. The appointment of Prithvi Raj as Chief AI and Data Officer at Waud Capital Partners is just one example of a much broader phenomenon reshaping how the sector operates.
Eighty-four percent of PE firms now have a Chief AI or Data Officer-a table-stakes requirement. CAIO appointments across 35,000 U.S. companies grew 70 percent year-over-year, reflecting a two-year transformation. PE hiring in AI and data roles accelerated 38 percent year-over-year. The message is clear: algorithmic capability is no longer optional. See the PE Hub announcement for details on how this trend is manifesting across the sector.
Why Healthcare Became the Proving Ground
Within PE, healthcare has been the sector most animated by AI investment. Healthcare AI startups raised $10.5 billion across 511 deals in 2024. That volume of capital targeting health-related machine learning speaks to a sector where AI creates measurable, immediate value. Unlike some industries where AI applications are speculative, healthcare AI solves concrete problems: predicting patient deterioration, matching treatments to individuals, optimizing supply chains, reducing administrative burden.
Reeve Waud specializes in healthcare and software. That focus puts the firm at the exact intersection where AI deployment is most advanced and most profitable. Healthcare PE firms without data capability are increasingly unable to compete with firms that can identify, evaluate, and embed AI solutions across their portfolio. Behavioral health provider insights help PE professionals understand market dynamics in this critical sector.
A clinical decision support system that improves diagnostic accuracy translates directly to patient outcomes and revenue. A predictive analytics platform that identifies which patients will default on payments or require preventive intervention creates immediate cash flow improvement. An administrative automation tool that reduces billing errors and speeds claims processing compounds across all portfolio companies operating in that space.
The PE firms moving fastest are the ones building in-house AI expertise rather than consulting it in, project by project. Reeve Waud’s board leadership at major healthcare platforms demonstrates his hands-on approach to value creation. Waud Capital’s creation of a Chief AI and Data Officer role signals this strategic commitment. Prithvi Raj will not be a consultant available for special projects. He will be embedded in investment decisions, portfolio operations, and management team guidance. That constant presence changes how value creation gets conceived from the earliest deal evaluation stage onward.
The Portfolio Company Angle
For healthcare portfolio companies, AI applications are concrete: predictive models in core products, historical data guiding referral patterns, demand forecasting, identifying patients at risk for rehospitalization. Reeve Waud’s venture capital profile shows his involvement across growth stage and early-stage investments. The PE firms with in-house data expertise can accelerate these innovations, hire the right talent, and model how clinical improvements translate to revenue.
PE firms without data capability take a wait-and-see approach. By the time they decide, competitors may have captured the advantage. This timing matters in healthcare, where regulatory constraints and integration timelines mean decisions made today play out for years. Partner promotions at Waud Capital reflect the firm’s focus on elevating talent capable of translating strategy into execution.
The Broader Sector Transformation
Two-thirds of PE firms expect to invest 25 percent or more of their portfolio capital budget in AI capabilities by 2026. That is the ultimate voting mechanism-how much capital is actually being deployed toward AI solutions. Those firms are not speculating. They are committing billions to the bet that AI works in their portfolio companies.
The empirical result so far is encouraging. Ninety-five percent of PE funds report that their AI initiatives are meeting or exceeding expectations. That is not a guarantee of future returns. But it is a signal that the capital being deployed is not being wasted. The firms moving early are learning lessons that later movers will have to replicate. For healthcare-focused PE specifically, the timing is critical. Healthcare is structurally capital-intensive. Every dollar of operational improvement compounds.
Reeve Waud’s appointment of Prithvi Raj reflects a calculation: we compete with other healthcare PE firms. Those competitors are all building AI capabilities. We cannot fall behind. We need world-class data expertise advising on every investment, every operational lever, every portfolio company hiring decision. In healthcare private equity, that decision is no longer optional.
